Cellectis Granted T Cell CRISPR Patent in Europe – Genetic Engineering & Biotechnology News (blog)
Genetic Engineering & Biotechnology News (blog) |
Cellectis Granted T Cell CRISPR Patent in Europe
Genetic Engineering & Biotechnology News (blog) The bitter patent feud over CRISPR, a gene-editing tool with unprecedented potential, continues in the United States. Meanwhile, French biotech Cellectis is staking a claim to the technology in Europe. Cellectis announced that the European Patent … Cellectis Granted Patent for CRISPR Use in T-Cells |
